Effective management of depressed mood with agomelatine, a melatonergic antidepressant

Effective management of depressed mood with agomelatine, a melatonergic antidepressant

Bibliographic Details
Main Author:	Goodwin, G
Format:	Journal article
Published:	2007

Similar Items

AGOMELATINE, THE FIRST MELATONERGIC ANTIDEPRESSANT: A SUSTAINED EFFICACY IN SEVERELY DEPRESSED PATIENTS
by: Montgomery, SA, et al.
Published: (2010)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
by: Robert H Howland
Published: (2009-11-01)

Agomelatine: A new insight into antidepressant efficacy
by: Goodwin, G
Published: (2012)

Antidepressant effect in older depressed patients: the lessons of two agomelatine trials
by: Goodwin, G, et al.
Published: (2017)

Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder
by: Goodwin, G, et al.
Published: (2007)

Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
by: Mei Gao, et al.
Published: (2023-03-01)

Clinical studies on the efficacy of agomelatine on depressive symptoms.
by: Goodwin, G
Published: (2009)

Melatonergic Drugs for Therapeutic Use in Insomnia and Sleep Disturbances of Mood Disorders
by: Srinivasan, Venkatramanujam, et al.
Published: (2012)

Melatonergic drugs in development
by: Carocci A, et al.
Published: (2014-09-01)

Adherence to antidepressant therapy: clinical experience on the example of agomelatine
by: N. N. Petrova
Published: (2022-08-01)

Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
by: George Anderson
Published: (2022-12-01)

Neuropharmacologic modulation of the melatonergic system
by: Utku Aykan, et al.
Published: (2023-12-01)

Agomelatine for postpartum depression and breastfeeding
by: Le Xiao
Published: (2021-06-01)

Antidepressants are not an effective adjunct to mood stabilisers for bipolar depression.
by: Rao, C, et al.
Published: (2007)

Melatonin, insomnia and the use of melatonergic drugs
by: Srinivasan, Venkatramanujam, et al.
Published: (2012)

Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
by: Andrea C. Rossetti, et al.
Published: (2022-10-01)

Efficacy and tolerability of agomelatine in the treatment of depression
by: Plesničar BK
Published: (2014-05-01)

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.
by: Goodwin, G, et al.
Published: (2013)

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine
by: Goodwin, G, et al.
Published: (2013)

Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT<sub>2C </sub>receptor-dependent pathways
by: Racagni Giorgio, et al.
Published: (2010-06-01)

The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents
by: Olumuyiwa John Fasipe
Published: (2019-06-01)

What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?
by: Petr Potměšil
Published: (2019-06-01)

Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months
by: Goodwin, G, et al.
Published: (2008)

Bipolar depression and treatment with antidepressants.
by: Goodwin, G
Published: (2012)

Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
by: Srinivasan, Venkataramanujan, et al.
Published: (2012)

Approaches to therapy for depressions in neurology: prospects for the use of agomelatine
by: D. V. Romanov, et al.
Published: (2018-12-01)

Cardiovascular Effects of Antidepressants and Mood Stabilizers
by: Shahin Akhondzadeh, et al.
Published: (2007-08-01)

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
by: Kasper, S, et al.
Published: (2010)

Antidepressants for bipolar depression.
by: Ghaemi, SN, et al.
Published: (2005)

Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression
by: L. I. Abramova, et al.
Published: (2019-06-01)

Comparing the effect of agomelatine and sertraline in treating patients with major depression disorder
by: Afshin Ahmadvand, et al.
Published: (2023-09-01)

Assessment of Melatonergics in Prevention of Delirium: A Systematic Review and Meta-Analysis
by: Yibing Zhu, et al.
Published: (2020-04-01)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
by: Pecenak J, et al.
Published: (2013-10-01)

Agomelatine facilitates positive emotional processing in healthy volunteers
by: Goodwin, G, et al.
Published: (2010)

Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study
by: Rebecca Robillard, et al.
Published: (2018-12-01)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
by: In Hee Shim, et al.
Published: (2017-11-01)

The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine
by: Paulina Wigner, et al.
Published: (2020-06-01)

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.
by: Corruble, E, et al.
Published: (2013)

AGOMELATINE VERSUS ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDERS : A RANDOMIZED DOUBLE-BLIND, LONG TERM STUDY FOCUSING ON SLEEP SATISFACTION AND EMOTIONAL BLUNTING
by: Corruble, E, et al.
Published: (2011)

AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: N. Yu. Shimohina, et al.
Published: (2017-03-01)